Differential diagnosis intrahepatic cholangiocarcinoma localization
https://doi.org/10.18027/2224-5057-2016-3-32-36
Abstract
On biopsy and surgical material of greatest difficulty in terms of differential morphological diagnosis of metastatic adenocarcinoma of various localizations are cholangiocellular carcinoma (CCK) and gepatocholangiocellular cancer (GCCK). Patients no history of myocardial indicated last parasitic or viral hepatitis. However, it should be noted that our observations both forms of cancer developing on the background cirrhosis.
About the Authors
R. V. ISCHENKO
Moscow Regional Oncological Center
Russian Federation
MD, PhD, DSc, head of the Oncology Department 11
Russian Federation
MD, PhD, DSc, head of the Oncology Department 11
M. A. ANDREEVA
Moscow Regional Oncological Center
Russian Federation
Russian Federation
head of the Pathology Department
E. V. YAKOVLEVA
Moscow Regional Oncological Center
Russian Federation
physician pathology department
Russian Federation
physician pathology department
K. B. ISHCHENKO
Moscow Regional Oncological Center
Russian Federation
Russian Federation
physician pathology department
References
1. Welzel T. M., McGlynn K.A., Hsing A. W. et al. Impact of classification of hilar cholangiocarcinomas (Klatskin tumors) on the incidence of intra- and extrahepatic cholangiocarcinoma in the United States. J Natl Cancer Inst. 2006; Vol. 98: p. 873–875.
2. B., Komuta M., Roskams T., Gores G. J. Clinical diagnosis and staging of cholangiocarcinoma. Nat Rev Gastroenterol Hepatol. 2011; Vol. 8: p. 512–522.
3. Deoliveira M. L., Schulick R. D., Nimura Y. et al. New staging system and a registry for perihilar cholangiocarcinoma. Hepatology. 2011; Vol. 53: p.1363–1371.
4. DeOliveira M.L., Cunningham S. C., Cameron J. L. et al. Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution. Ann Surg. 2007; Vol. 245: p.755– 762.
5. Blechacz B. G., G. J. Feldman: Sleisenger and Fordtran’s Gastrointestinal and Liver Disease. 9. Vol. 1. Saunders; 2010. Tumors of the Bile Ducts, Gallbladder, and Ampulla; pp. 1171–1176.
6. Khan S. A., Davidson B. R., Goldin R. D. et al. Guidelines for the diagnosis and treatment of cholangiocarcinoma: an update. Gut. 2012; Vol.61: p.1657–69.
7. Everhart J. E., Ruhl C. E. Burden of digestive diseases in the United States Part III: Liver, biliary tract, and pancreas. Gastroenterology. 2009; Vol.136: p.1134–1144.
8. Tyson G. L., El-Serag H. B. Risk factors forcholangiocarcinoma. Hepatology. 2011; Vol. 54: p.173–184.
9. Shaib Y., El-Serag H. B. The epidemiology of cholangiocarcinoma. Semin Liver Dis. 2004; Vol. 24: p.115–125.
10. Sripa B., Pairojkul C. Cholangiocarcinoma: lessons from Thailand. Curr Opin Gastroenterol. 2008; Vol. 24: p.349–356.
11. Khan S. A., Taylor-Robinson S.D., Toledano M. B. et al. Changing international trends in mortality rates for liver, biliary and pancreatic tumours. J Hepatol. 2002; Vol. 37: p.806–813. 12. Khan S. A., Toledano M. B., Taylor-Robinson S. D. Epidemiology, risk factors, and pathogenesis of cholangiocarcinoma. HPB (Oxford) 2008; Vol. 10: p.77–82.
12. McGlynn K.A., Tarone R. E., El-Serag H.B. A comparison of trends in the incidence of hepatocellular carcinoma and intrahepatic cholangiocarcinoma in the United States. Cancer Epidemiol Biomarkers Prev. 2006; Vol. 15: p. 1198–1203.
13. Patel T. Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States. Hepatology. 2001; Vol. 33: p.1353–1357.
14. Patel T. Worldwide trends in mortality from biliary tractmalignancies. BMC Cancer. 2002; Vol. 2: p.10.
15. Khan S. A., Emadossadaty S., Ladep N. G. et al. Rising trends in cholangiocarcinoma: Is the ICD classification system misleading us? Journal of Hepatology. 2012; Vol. 56: p.848– 854.
16. Razumilava N., Gores G. J. Classification, diagnosis, and management of cholangiocarcinoma. Clin Gastroenterol Hepatol. 2013; Vol. 11: p.13–21.
17. Shin H. R., Oh J. K., Lim M. K. et al. Descriptive epidemiology of cholangiocarcinoma and clonorchiasis in Korea. J Korean Med Sci. 2010; Vol. 25: p. 1011–1016.
18. Huang M. H., Chen C. H., Yen C. M. et al. Relation of hepatolithiasis to helminthic infestation. J Gastroenterol Hepatol. 2005; Vol.20: p.141–146.
19. Edil B. H., Cameron J. L., Reddy S. et al. Choledochal cyst disease in children and adults: a 30-year singleinstitution experience. J Am Coll Surg. 2008; Vol. 206: p1000–1005. discussion 1005–8.
20. Mabrut J. Y., Bozio G., Hubert C., Gigot J. F. Management of congenital bile duct cysts. Dig Surg. 2010; Vol. 27: p 12–18.
Review
For citations:
ISCHENKO R.V., ANDREEVA M.A., YAKOVLEVA E.V., ISHCHENKO K.B. Differential diagnosis intrahepatic cholangiocarcinoma localization. Malignant tumours. 2016;(3):32-36. (In Russ.) https://doi.org/10.18027/2224-5057-2016-3-32-36
Views:
1682
Email this article 